Revised algorithm for heparin anticoagulation during continuous renal replacement therapy
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1364-8535
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Revised algorithm for heparin anticoagulation during continuous renal replacement therapy ; volume:19 ; number:1 ; day:1 ; month:12 ; year:2015 ; pages:1-2 ; date:12.2015
Critical care ; 19, Heft 1 (1.12.2015), 1-2, 12.2015
- Urheber
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s13054-015-1099-y
- URN
-
urn:nbn:de:101:1-2021102920242270952202
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:37 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Dickie, Helen
- Tovey, Linda
- Berry, William
- Ostermann, Marlies
- SpringerLink (Online service)
Ähnliche Objekte (12)
Citrate anticoagulation and systemic heparin anticoagulation during continuous renal replacement therapy among critically-ill children
Citrate versus heparin anticoagulation in continuous renal replacement therapy in small children
Citrate and low-dose heparin combined anticoagulation in pediatric continuous renal replacement therapy
Unfractionated heparin versus nafamostat mesylate for anticoagulation during continuous kidney replacement therapy: an observational study
Correction: Unfractionated heparin versus nafamostat mesylate for anticoagulation during continuous kidney replacement therapy: an observational study
Continuous kidney replacement therapy in critically ill children: heparin vs citrate
Complications of Regional Citrate Anticoagulation for Continuous Renal Replacement Therapy: An Observational Study
Regional citrate versus heparin anticoagulation for continuous renal replacement therapy in critically ill patients: a meta-analysis with trial sequential analysis of randomized controlled trials
Efficacy and safety of citrate-based anticoagulation compared to heparin in patients with acute kidney injury requiring continuous renal replacement therapy: a randomized controlled trial
Low bicarbonate replacement fluid normalizes metabolic alkalosis during continuous veno-venous hemofiltration with regional citrate anticoagulation
Heparin-Induced Thrombocytopenia in Healthy Individuals with Continuous Heparin Infusion
Analysis of Anticoagulation Activities of Heparins - Is usp Heparin Assay Reliable?
Citrate anticoagulation and systemic heparin anticoagulation during continuous renal replacement therapy among critically-ill children
Citrate versus heparin anticoagulation in continuous renal replacement therapy in small children
Citrate and low-dose heparin combined anticoagulation in pediatric continuous renal replacement therapy
Unfractionated heparin versus nafamostat mesylate for anticoagulation during continuous kidney replacement therapy: an observational study
Correction: Unfractionated heparin versus nafamostat mesylate for anticoagulation during continuous kidney replacement therapy: an observational study
Continuous kidney replacement therapy in critically ill children: heparin vs citrate
Complications of Regional Citrate Anticoagulation for Continuous Renal Replacement Therapy: An Observational Study
Regional citrate versus heparin anticoagulation for continuous renal replacement therapy in critically ill patients: a meta-analysis with trial sequential analysis of randomized controlled trials
Efficacy and safety of citrate-based anticoagulation compared to heparin in patients with acute kidney injury requiring continuous renal replacement therapy: a randomized controlled trial
Low bicarbonate replacement fluid normalizes metabolic alkalosis during continuous veno-venous hemofiltration with regional citrate anticoagulation
Heparin-Induced Thrombocytopenia in Healthy Individuals with Continuous Heparin Infusion
Analysis of Anticoagulation Activities of Heparins - Is usp Heparin Assay Reliable?
Citrate anticoagulation and systemic heparin anticoagulation during continuous renal replacement therapy among critically-ill children
Citrate versus heparin anticoagulation in continuous renal replacement therapy in small children
Citrate and low-dose heparin combined anticoagulation in pediatric continuous renal replacement therapy
Unfractionated heparin versus nafamostat mesylate for anticoagulation during continuous kidney replacement therapy: an observational study
Correction: Unfractionated heparin versus nafamostat mesylate for anticoagulation during continuous kidney replacement therapy: an observational study
Continuous kidney replacement therapy in critically ill children: heparin vs citrate
Complications of Regional Citrate Anticoagulation for Continuous Renal Replacement Therapy: An Observational Study
Regional citrate versus heparin anticoagulation for continuous renal replacement therapy in critically ill patients: a meta-analysis with trial sequential analysis of randomized controlled trials
Efficacy and safety of citrate-based anticoagulation compared to heparin in patients with acute kidney injury requiring continuous renal replacement therapy: a randomized controlled trial
Low bicarbonate replacement fluid normalizes metabolic alkalosis during continuous veno-venous hemofiltration with regional citrate anticoagulation
Heparin-Induced Thrombocytopenia in Healthy Individuals with Continuous Heparin Infusion